LENSAR Inc. (LNSR)
7.75
-0.31 (-3.85%)
At close: Jan 14, 2025, 3:59 PM
7.66
-1.11%
After-hours Jan 14, 2025, 04:00 PM EST
undefined% (undefined)
| Bid | 3.07 |
| Market Cap | 89.97M |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | -1.43 |
| PE Ratio (ttm) | -5.42 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 9.56 |
| Volume | 41,687 |
| Avg. Volume (20D) | 49,414 |
| Open | 8.00 |
| Previous Close | 8.06 |
| Day's Range | 7.63 - 8.06 |
| 52-Week Range | 2.67 - 9.23 |
| Beta | undefined |
About LNSR
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, d...
Industry Medical - Devices
Sector Healthcare
IPO Date Oct 2, 2020
Employees 130
Stock Exchange NASDAQ
Ticker Symbol LNSR
Website https://www.lensar.com
Next Earnings Release
LENSAR Inc. is scheduled to release its earnings on Mar 3, 2025,
before market opens.
Analysts project revenue of $14.95M, reflecting a 23.50% YoY growth and earnings per share of -0.18, making a -48.57% decrease YoY.
Analysts project revenue of $14.95M, reflecting a 23.50% YoY growth and earnings per share of -0.18, making a -48.57% decrease YoY.
